Second-Generation Antipsychotic Treatment Indication Effectiveness and Tolerability in Youth Study (SATIETY)

Focus of Study:

Weight gain monitoring in persons taking antipsychotic medication

Purpose:

This research study is a weight gain monitoring study. It is not a treatment study and there are no study medications to take. Research study participants will be monitored (physical exam, blood work, and meeting with study physician) at 7 time points through one year.

Subjects may be paid up to $175 to participate in and complete this study. Study visits will be free of charge (including lab work), and transportation may be provided if needed.

Enrollment:

200

Primary Completion Date:

TBD

Ages of Eligibility:

3-19 years

Inclusion Criteria:

Between the ages of 3 and 19, male or female, any race or ethnicity
Diagnosis of Schizophrenia Spectrum Disorder, Bipolar Spectrum Disorder, or Mood Disorder NOS
Currently taking olanzapine, quetiapine, risperidone, ziprasidone, or aripiprazole

Exclusion Criteria:

Severe medical disorder (i.e., AIDS, cancer, sepsis, etc)
Active hyper-/hypothyroidism
Any current or past diagnosis of an eating disorder
Pregnancy or breast feeding

Contacts:

Contact person: Adrienne Albano

Phone: 1-800-708-0048

E-mail: ASPIRE@unc.edu

Locations:

UNC outpatient/UNC inpatient

Sponsors & Collaborators:

Foundation of Hope

Investigators:

Linmarie Sikich, MD